latest news releases from the newsroom
Utilities Need to Help Large Users Track Energy Usage, Effects of Energy Saving Efforts, New Chartwell Report Says
ATLANTA, Sept. 28, 2004 (PRIMEZONE) -- Savvy utilities offer energy usage data to help large customers in their energy efficiency efforts -- such as in benchmarking, energy profile development, energy saving tracking and more. But utilities shouldn't simply make the data available, according to Chartwell's new report, Internet-Based Energy Data and Analysis For C&I Customers. End-users need to be educated about the value of timely energy usage data because they are not sure how to best utilize the data. In addition, large customers who try to manage energy efficiency want solutions, not just a load profile. They want the utility to inform them when there is a problem and advise what to do about it, according to Chartwell's research.
Reach Your Sexual Potential With This New Book
BOCA RATON, Fla., Sept. 28, 2004 (PRIMEZONE) -- Now every man can move beyond ordinary hit or miss sex and achieve total sexual self-mastery. Dr. Douglas Schooler's Super Virility shows you how to control every aspect of your sexuality, from desire and arousal to performance, enhancing your satisfaction and recharging a couple's relationship.
Gardant Pharmaceuticals, Inc.
Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde
NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a developer of products focused on cardiovascular drugs, has entered into an exclusive license and co-development agreements with the University of Strathclyde, Scotland. Under the terms of these agreements, Inncardio Inc. will benefit from certain exclusive commercial rights and the University of Strathclyde will receive a combination of research funding, development milestones and royalty payments. INC 105 is being co-developed by the University of Strathclyde and Inncardio Inc. for the prevention of restenosis in percutaneous transluminal balloon angioplasty and other percutaneous coronary interventions in particular arterial stenting. It is envisaged that INC 105 will be delivered from drug eluting stents using proprietary polymer technology.
Sharp Holding Corporation
SCAN USA President Interviewed by Wall Street Reporter
HOUSTON, Sept. 28, 2004 (PRIMEZONE) -- Lou Schwartz, President of SCAN USA, a wholly owned subsidiary of Sharp Holding Corp (OTCBB:SHAR), was interviewed by the Wall Street Reporter on September 24, 2004. During the interview, Mr. Schwartz outlined the business and marketing plan of SCAN USA. SCAN USA is designed to be the first national emergency alert system that allows local police departments and public safety agencies to broadcast alerts to the PCs, cell phones, pagers and PDA's of their neighborhood and local residents. SCAN USA has announced an exclusive marketing partnership with SBC Communications to provide alerts free of charge to SBC customers in SBC's thirteen state territory. The program is planned to begin in California during October, 2004.
Two Cribs in the Corner: A Disturbing New Novel about Obsession
CLEMENTON, N.J., Sept. 28, 2004 (PRIMEZONE) -- Nurse Allie is sick, and she has a dirty little secret. She stole a baby from the hospital and raised the child as her own. Allie originally had a different plan. She propositioned a young mother to give up her child, but the baby was dead at birth. In desperation, Allie snatched another baby from the nursery. She did not know that the baby was one of twins. And that someone had seen her commit the crime.
Converium Holding AG
Converium: Extraordinary General Meeting approves Capital Increase
ZUG, Switzerland, Sept. 28, 2004 (PRIMEZONE) -- At the Extraordinary General Meeting of Converium held in Zurich today, shareholders have approved the reduction of the nominal value from CHF 10 per share by CHF 5 to CHF 5 per share and the increase of the share capital by CHF 533,416,225 through the issuance of 106,683,245 fully paid registered shares with a nominal value of CHF 5 each at an issue price of CHF 5.00 per share.